Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Antimicrobial therapy
01
Overview
"Antimicrobial therapy" refers to the clinical application of antimicrobial agents (antibiotics, antivirals, antifungals, antiparasitics) for the treatment or prevention of infectious diseases. These agents act by targeting specific molecular components of microorganisms, such as cell wall biosynthetic enzymes, ribosomal subunits, metabolic pathways, and nucleic acid synthesis enzymes, thereby inhibiting growth or killing the pathogens[1][2][8]. The concept does not relate to a distinct molecular target, but rather to the collective use of drugs that interact with a wide range of microbial molecules.
- Other names
- antimicrobial chemotherapyantimicrobial treatment
Beyond the preview
Go deeper on Antimicrobial therapy.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Antimicrobial therapy.